Literature DB >> 20185605

Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.

Jean-Philippe Haymann1, Katia Stankovic, Pierre Levy, Virginie Avellino, Pierre-Louis Tharaux, Emmanuel Letavernier, Gilles Grateau, Laurent Baud, Robert Girot, François Lionnet.   

Abstract

BACKGROUND AND OBJECTIVES: Sickle cell anemia-associated nephropathy is a growing matter of concern because renal failure affects most aging sickle cell anemia patients. Glomerular damage is a common feature revealed by a microalbuminuria or a macroalbuminuria. Although glomerular hyperfiltration has been described for decades in this population, its prevalence in young adults is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To address this issue, as well as the clinical and biologic correlates of hyperfiltration, a single-center, cross-sectional study of 280 homozygous SS disease patients was performed.
RESULTS: The prevalence of hyperfiltration assessed by Modification of Diet in Renal Disease estimated GFR was 51%. Among patients with hyperfiltration, 49% had hyperfiltration alone, whereas 36% and 15% had an associated microalbuminuria or macroalbuminuria, respectively. Estimated GFR sensitivity and specificity for hyperfiltration were 94% and 63%, respectively, in a selected subgroup of 48 patients (measured GFR was assessed by urinary (51)Cr EDTA clearance). In patients with no albuminuria, hyperfiltration status was significantly associated with a young age (years), the absence of alpha thalassemia, a lower hemoglobin level (g/dl), and a lower fetal hemoglobin. The role of chronic hemolysis was further strengthened by multivariate analysis showing a correlation between estimated GFR and a low plasma fetal hemoglobin level, a young age, and a high reticulocyte count (r(2) = 0.54).
CONCLUSIONS: Together, the data suggest that the pathophysiology of hyperfiltration would rather be attributable to the hemolysis-associated vasculopathy rather than a viscosity-vaso-occlusive process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185605      PMCID: PMC2863976          DOI: 10.2215/CJN.08511109

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia.

Authors:  José Herrera; Estela Avila; Crispín Marín; Bernardo Rodríguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2002-04       Impact factor: 5.992

3.  Glomerular hyperfiltration in microalbuminuric NIDDM patients.

Authors:  P Vedel; J Obel; F S Nielsen; L E Bang; T L Svendsen; O B Pedersen; H H Parving
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

4.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

5.  Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.

Authors:  R J Falk; J Scheinman; G Phillips; E Orringer; A Johnson; J C Jennette
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

6.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

8.  Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption.

Authors:  Avry Chagnac; Michal Herman; Boris Zingerman; Arie Erman; Benaya Rozen-Zvi; Judith Hirsh; Uzi Gafter
Journal:  Nephrol Dial Transplant       Date:  2008-07-12       Impact factor: 5.992

9.  Enalapril reduces the albuminuria of patients with sickle cell disease.

Authors:  R Y Aoki; S T Saad
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

10.  Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.

Authors:  Joanne Thompson; Marvin Reid; Ian Hambleton; Graham R Serjeant
Journal:  Arch Intern Med       Date:  2007-04-09
View more
  53 in total

1.  Increased clearance of morphine in sickle cell disease: implications for pain management.

Authors:  Deepika S Darbari; Michael Neely; John van den Anker; Sohail Rana
Journal:  J Pain       Date:  2011-02-01       Impact factor: 5.820

2.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

Review 4.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 5.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

6.  Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.

Authors:  Malgorzata Kasztan; Brandon M Fox; Jeffrey D Lebensburger; Kelly A Hyndman; Joshua S Speed; Jennifer S Pollock; David M Pollock
Journal:  Blood Adv       Date:  2019-05-14

7.  Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Authors:  Stéphane Maurel; Katia Stankovic Stojanovic; Virginie Avellino; Alexey Girshovich; Emmanuel Letavernier; Gilles Grateau; Laurent Baud; Robert Girot; Francois Lionnet; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

8.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

9.  Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Barry L Shulkin; Jane S Hankins; Russell E Ware
Journal:  Am J Hematol       Date:  2012-12-17       Impact factor: 10.047

10.  Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.

Authors:  Julia Z Xu; Melanie E Garrett; Karen L Soldano; Sean T Chen; Clary B Clish; Allison E Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2018-09-27       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.